NCT05111574 | A091903 | ALLIANCE

NCT Number: NCT05111574

Protocol ID: A091903

Sponsor: ALLIANCE

Disease Site: Melanoma

Disease Category: Melanoma

Detail: A Randomized Phase II Trial of Adjuvant Nivolumab with or Without Cabozantinib in Patients with Resected Mucosal Melanoma

Interested in participating in this trial?

Clinical Trial

First Name

Last Name

Phone

Preferred Contact Method:

Preferred Location:

Patient Type:

Current Patient New Patient

Interested in:

Cancer Clinical Trial Blood Disorder Clinical Trial

Disease Site:

Disease Category

The National Clinical Trial (NTC) is assigned by the National Library of Medicine when a new study appears in the clinical trials database.

ex: NCT0526225 | GY026 | NRG

Any unique identifier assigned to the protocol by the sponsor.

ex: NCT0526225 | GY026 | NRG

A sponsor is an individual, institution, company or organization that takes the responsibility to initiate, manage and/or finance the clinical trial.

ex: NCT0526225 | GY026 | NRG